Tendolkar, Indira <br/><br/>
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.  [electronic resource] 

 -  International journal of geriatric psychiatry  Jan 2012 
 - 49-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1166 
<br/><br/><label>Standard No.: </label>10.1002/gps.2688  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Anticholesteremic Agents--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Atorvastatin<br/>Atrial Fibrillation--drug therapy<br/>Atrophy--drug therapy<br/>Azetidines--therapeutic use<br/>Biomarkers--blood<br/>Cholesterol--blood<br/>Double-Blind Method<br/>Ezetimibe<br/>Female<br/>Heptanoic Acids--therapeutic use<br/>Humans<br/>Male<br/>Memory--drug effects<br/>Memory Disorders--drug therapy<br/>Neuropsychological Tests<br/>Pyrroles--therapeutic use<br/>Temporal Lobe--pathology